IBDEI04L ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5850,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,5851,0)
 ;;=V16.3^^48^429^9
 ;;^UTILITY(U,$J,358.3,5851,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5851,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,5851,1,5,0)
 ;;=5^Family H/O Cancer Of Breast
 ;;^UTILITY(U,$J,358.3,5851,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,5852,0)
 ;;=V16.41^^48^429^12
 ;;^UTILITY(U,$J,358.3,5852,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5852,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,5852,1,5,0)
 ;;=5^Family H/O Cancer Of Ovary
 ;;^UTILITY(U,$J,358.3,5852,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,5853,0)
 ;;=V16.42^^48^429^13
 ;;^UTILITY(U,$J,358.3,5853,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5853,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,5853,1,5,0)
 ;;=5^Family H/O Cancer Of Prostate
 ;;^UTILITY(U,$J,358.3,5853,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,5854,0)
 ;;=V16.43^^48^429^14
 ;;^UTILITY(U,$J,358.3,5854,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5854,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,5854,1,5,0)
 ;;=5^Family H/O Cancer Of Testis
 ;;^UTILITY(U,$J,358.3,5854,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,5855,0)
 ;;=V19.5^^48^429^15
 ;;^UTILITY(U,$J,358.3,5855,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5855,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,5855,1,5,0)
 ;;=5^Family H/O Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,5855,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,5856,0)
 ;;=V19.2^^48^429^16
 ;;^UTILITY(U,$J,358.3,5856,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5856,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,5856,1,5,0)
 ;;=5^Family H/O Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,5856,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,5857,0)
 ;;=V17.3^^48^429^18
 ;;^UTILITY(U,$J,358.3,5857,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5857,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,5857,1,5,0)
 ;;=5^Family H/O Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,5857,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,5858,0)
 ;;=V16.6^^48^429^19
 ;;^UTILITY(U,$J,358.3,5858,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5858,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,5858,1,5,0)
 ;;=5^Family H/O Leukemia
 ;;^UTILITY(U,$J,358.3,5858,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,5859,0)
 ;;=V18.61^^48^429^21
 ;;^UTILITY(U,$J,358.3,5859,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5859,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,5859,1,5,0)
 ;;=5^Family H/O Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,5859,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,5860,0)
 ;;=V17.0^^48^429^22
 ;;^UTILITY(U,$J,358.3,5860,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5860,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,5860,1,5,0)
 ;;=5^Family H/O Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,5860,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,5861,0)
 ;;=V19.4^^48^429^23
 ;;^UTILITY(U,$J,358.3,5861,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5861,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,5861,1,5,0)
 ;;=5^Family H/O Skin Condition
 ;;^UTILITY(U,$J,358.3,5861,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,5862,0)
 ;;=V17.1^^48^429^24
 ;;^UTILITY(U,$J,358.3,5862,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5862,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,5862,1,5,0)
 ;;=5^Family H/O Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,5862,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,5863,0)
 ;;=V16.8^^48^429^20
 ;;^UTILITY(U,$J,358.3,5863,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5863,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,5863,1,5,0)
 ;;=5^Family H/O Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,5863,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,5864,0)
 ;;=V11.1^^48^429^47
 ;;^UTILITY(U,$J,358.3,5864,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5864,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,5864,1,5,0)
 ;;=5^Personal H/O Affective Disorder
 ;;^UTILITY(U,$J,358.3,5864,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,5865,0)
 ;;=V15.89^^48^429^55
 ;;^UTILITY(U,$J,358.3,5865,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5865,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,5865,1,5,0)
 ;;=5^Personal H/O Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,5865,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,5866,0)
 ;;=V11.3^^48^429^48
 ;;^UTILITY(U,$J,358.3,5866,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5866,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,5866,1,5,0)
 ;;=5^Personal H/O Alcoholism
 ;;^UTILITY(U,$J,358.3,5866,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,5867,0)
 ;;=V15.07^^48^429^49
 ;;^UTILITY(U,$J,358.3,5867,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5867,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,5867,1,5,0)
 ;;=5^Personal H/O Allergy to Latex
 ;;^UTILITY(U,$J,358.3,5867,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,5868,0)
 ;;=V13.4^^48^429^50
 ;;^UTILITY(U,$J,358.3,5868,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5868,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,5868,1,5,0)
 ;;=5^Personal H/O Arthritis
 ;;^UTILITY(U,$J,358.3,5868,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,5869,0)
 ;;=V12.72^^48^429^51
 ;;^UTILITY(U,$J,358.3,5869,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5869,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,5869,1,5,0)
 ;;=5^Personal H/O Colon Polyps
 ;;^UTILITY(U,$J,358.3,5869,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,5870,0)
 ;;=V12.59^^48^429^52
 ;;^UTILITY(U,$J,358.3,5870,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5870,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,5870,1,5,0)
 ;;=5^Personal H/O Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,5870,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,5871,0)
 ;;=V45.81^^48^429^53
 ;;^UTILITY(U,$J,358.3,5871,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5871,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,5871,1,5,0)
 ;;=5^Personal H/O Coronary Bypass
 ;;^UTILITY(U,$J,358.3,5871,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,5872,0)
 ;;=V15.84^^48^429^54
 ;;^UTILITY(U,$J,358.3,5872,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5872,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,5872,1,5,0)
 ;;=5^Personal H/O Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,5872,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,5873,0)
 ;;=V15.85^^48^429^60
 ;;^UTILITY(U,$J,358.3,5873,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5873,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,5873,1,5,0)
 ;;=5^Personal H/O Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,5873,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,5874,0)
 ;;=V10.72^^48^429^56
 ;;^UTILITY(U,$J,358.3,5874,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5874,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,5874,1,5,0)
 ;;=5^Personal H/O Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,5874,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,5875,0)
 ;;=V15.3^^48^429^57
 ;;^UTILITY(U,$J,358.3,5875,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5875,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,5875,1,5,0)
 ;;=5^Personal H/O Irradiation
 ;;^UTILITY(U,$J,358.3,5875,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,5876,0)
 ;;=V10.61^^48^429^32
 ;;^UTILITY(U,$J,358.3,5876,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5876,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,5876,1,5,0)
 ;;=5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,5876,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,5877,0)
 ;;=V12.03^^48^429^33
 ;;^UTILITY(U,$J,358.3,5877,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5877,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,5877,1,5,0)
 ;;=5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,5877,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,5878,0)
 ;;=V10.82^^48^429^34
 ;;^UTILITY(U,$J,358.3,5878,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5878,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,5878,1,5,0)
 ;;=5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,5878,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,5879,0)
 ;;=V10.62^^48^429^36
 ;;^UTILITY(U,$J,358.3,5879,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5879,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,5879,1,5,0)
 ;;=5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,5879,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,5880,0)
 ;;=V10.63^^48^429^35
 ;;^UTILITY(U,$J,358.3,5880,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5880,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,5880,1,5,0)
 ;;=5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,5880,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,5881,0)
 ;;=V11.2^^48^429^30
 ;;^UTILITY(U,$J,358.3,5881,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5881,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,5881,1,5,0)
 ;;=5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,5881,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,5882,0)
 ;;=V15.81^^48^429^46
 ;;^UTILITY(U,$J,358.3,5882,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5882,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,5882,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,5882,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,5883,0)
 ;;=V10.43^^48^429^37
 ;;^UTILITY(U,$J,358.3,5883,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5883,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,5883,1,5,0)
 ;;=5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,5883,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,5884,0)
 ;;=V12.71^^48^429^38
 ;;^UTILITY(U,$J,358.3,5884,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5884,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,5884,1,5,0)
 ;;=5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,5884,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,5885,0)
 ;;=V10.46^^48^429^39
 ;;^UTILITY(U,$J,358.3,5885,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5885,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,5885,1,5,0)
 ;;=5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,5885,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,5886,0)
 ;;=V11.0^^48^429^40
 ;;^UTILITY(U,$J,358.3,5886,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5886,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,5886,1,5,0)
 ;;=5^Hx Of Schizophrenia
 ;;^UTILITY(U,$J,358.3,5886,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,5887,0)
 ;;=V10.83^^48^429^41
 ;;^UTILITY(U,$J,358.3,5887,1,0)
 ;;=^358.31IA^5^2
